GSK to launch Phase 3 test of mRNA flu vaccine with newer formulation
GSK on Tuesday said it will start a late-stage trial of its mRNA vaccine for seasonal influenza after the candidate delivered “higher immune responses” than traditional vaccines in a Phase 2 test. The UK pharma ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- GSK to advance mRNA seasonal flu vaccine to phase 3 trial seekingalpha.com
